RxSight (RXST) Non-Current Assets (2020 - 2026)
RxSight's (RXST) quarterly Non-Current Assets came in at $24.8 million in Q1 2026, up 0.56% YoY from $24.6 million in Q1 2025, and up 1.7% on a QoQ basis from $24.4 million in Q4 2025.
RxSight (RXST) Non-Current Assets (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Non-Current Assets data on file, last reported at $24.8 million in Q1 2026.
- Quarterly Non-Current Assets rose 0.56% year-over-year to $24.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98.9 million (up 1.61% YoY) and the FY2025 annual result came in at $24.4 million, down 1.56% from the prior year.
- Non-Current Assets rose to $24.8 million in Q1 2026, from $24.4 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $25.1 million in Q2 2025 to a low of $13.9 million in Q3 2023.
- A 5-year average of $19.6 million and a median of $16.8 million in 2022 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2023 — Non-Current Assets retreated 15.96% — and 2024, when it jumped 74.93%.
- Tracing RXST's Non-Current Assets over 5 years: stood at $15.6 million in 2022, then fell by 9.39% to $14.1 million in 2023, then jumped by 74.93% to $24.7 million in 2024, then dropped by 1.56% to $24.4 million in 2025, then grew by 1.7% to $24.8 million in 2026.
- The last three Non-Current Assets figures came in at $24.8 million (Q1 2026), $24.4 million (Q4 2025), and $24.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.61 Bn | 197.01 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 127.33 Bn | 123.85 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 119.23 Bn | 110.01 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 74.53 Bn | 73.99 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.84 Bn | 47.59 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 35.08 Bn | 33.14 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.86 Bn | 31.75 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.26 Bn | 22.94 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 8.29 Bn |
| 10 | RxSight | 259.73 Mn | -144.51 Mn | - | 25.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.30 Mn |
| Mar 31, 2026 | 24.77 Mn |
| Dec 31, 2025 | 24.36 Mn |
| Sep 30, 2025 | 24.66 Mn |
| Jun 30, 2025 | 25.14 Mn |
| Mar 31, 2025 | 24.63 Mn |
| Dec 31, 2024 | 24.74 Mn |
| Sep 30, 2024 | 23.70 Mn |
| Jun 30, 2024 | 24.28 Mn |
| Mar 31, 2024 | 14.61 Mn |
| Dec 31, 2023 | 14.14 Mn |
| Sep 30, 2023 | 13.90 Mn |
| Jun 30, 2023 | 14.82 Mn |
| Mar 31, 2023 | 14.87 Mn |
| Dec 31, 2022 | 15.61 Mn |
| Sep 30, 2022 | 16.54 Mn |
| Jun 30, 2022 | 16.79 Mn |
| Mar 31, 2022 | 15.92 Mn |
| Dec 31, 2021 | 16.43 Mn |
| Sep 30, 2021 | 17.40 Mn |